This guideline covers diagnosing and managing venous thromboembolic diseases in adults. It supports rapid diagnosis and effective treatment for DVT or PE. It also covers testing for conditions that predispose to VTE such as thrombophilia and cancer.
Guidelines on the diagnosis and management of acute pulmonary embolism from the European Society of Cardiology (ESC) endorsed by the European Respiratory Society (ERS)
Patients with PE should be assessed for suitability for management as outpatients (OPs). Patients assessed as low risk and suitable for OP management should be offered treatment in an OP setting where a robust pathway exists for follow-up and monitoring.
For VTE and no cancer, as long-term anticoagulant therapy, we suggest dabigatran, rivaroxaban, apixaban, or edoxaban over vitamin K antagonist (VKA) therapy, and suggest VKA therapy over low-molecular-weight heparin. For VTE and cancer, we suggest LMWH over VKA,
dabigatran, rivaroxaban, apixaban, or edoxaban.
U.K. National Institute for health and clinical excellence quality standard covering the diagnosis and treatment of venous thromboembolic diseases in adults, excluding pregnant women.
Institute for clinical systems improvement Healthcare Guideline on Venous Thromboembolism Diagnosis and Treatment
National Institute for health and clinical excellence (NICE) clinical guideline on Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing covers diagnostic tests for initial assessment of suspected VTE and interventions to manage venous thromboembolic diseases.
American College of Chest Physicians Evidence-Based Clinical Practice Guidelines on Antithrombotic Therapy and Prevention of Thrombosis
This scientific statement from the American Heart Association (AHA) provides evidence based recommendations for the management of patients with massive and submassive pulmonary embolism (PE), iliofemoral deep vein thrombosis (DVT), and chronic thromboembolic pulmonary hypertension (CTEPH).
Evidence based guidelines produced by the National Institute of Clinical Excellence (UK) on reducing the risk of Venous Thromboembolim, (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. Includes ten key priorities for implementation including assessing all patients on admission to identify those who are at increased risk of venous thromboembolism.
An Official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline: Evaluation of Suspected Pulmonary Embolism In Pregnancy